Physician profile
Katherine Podraza
NPI 1457731986
$8,272.57
in general payments reported to CMS, 2019-2025
13 companies · $7,257 in 2025
The $7,257 reported for 2025 was more than what 89% of Pain Medicine (Psychiatry & Neurology) providers received nationally (typical 2025 total: $405).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $125 · 2021: $14.54 · 2022: $14.39 · 2023: $199 · 2024: $662 · 2025: $7,257.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $6,663 · Food and Beverage: $1,456.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $6,662.50 |
| Food and Beverage | $1,456.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $7,328.35 | 2021-2025 | |
| Pfizer INC. | $278.91 | 2023-2025 | |
| Lundbeck LLC | $229.30 | 2024 | Vyepti |
| Amgen INC. | $125.00 | 2019 | |
| Emd Serono, INC. | $88.65 | 2023-2025 | Mavenclad |
| Depuy Synthes Sales INC. | $39.92 | 2025 | Cerepak Uniform |
| Ucb, INC. | $35.12 | 2024 | Rystiggo |
| Vanda Pharmaceuticals INC. | $31.28 | 2025 | Ponvory |
| Eisai INC. | $29.47 | 2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $25.91 | 2025 | Hyqvia |
| Genentech USA, INC. | $24.53 | 2024 | Ocrevus |
| Scilex Pharmaceuticals INC. | $24.32 | 2025 | |
| Sumitomo Pharma America, INC. | $11.81 | 2023 | Aptiom |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Katherine Podraza listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.